Simulations Plus, Inc. (NASDAQ:SLP) was upgraded by research analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Thursday.

Separately, Zacks Investment Research lowered shares of Simulations Plus from a “buy” rating to a “hold” rating in a research report on Wednesday, September 20th.

Simulations Plus (NASDAQ SLP) opened at 16.45 on Thursday. Simulations Plus has a one year low of $8.10 and a one year high of $17.40. The company has a market capitalization of $283.68 million, a PE ratio of 52.22 and a beta of -0.70. The stock’s 50 day moving average is $15.09 and its 200 day moving average is $13.18.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings results on Friday, July 14th. The technology company reported $0.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.02. Simulations Plus had a net margin of 24.86% and a return on equity of 23.21%. The company had revenue of $6.75 million for the quarter, compared to analyst estimates of $6.48 million. On average, analysts anticipate that Simulations Plus will post $0.32 earnings per share for the current fiscal year.

WARNING: This piece of content was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/07/bidaskclub-upgrades-simulations-plus-inc-slp-to-buy.html.

In related news, major shareholder Walter S. Woltosz sold 18,500 shares of the company’s stock in a transaction that occurred on Wednesday, September 27th. The shares were sold at an average price of $15.45, for a total transaction of $285,825.00. Following the sale, the insider now owns 5,647,916 shares of the company’s stock, valued at approximately $87,260,302.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 36.93% of the company’s stock.

A number of institutional investors have recently bought and sold shares of SLP. The Manufacturers Life Insurance Company increased its holdings in Simulations Plus by 13.8% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 8,923 shares of the technology company’s stock worth $110,000 after acquiring an additional 1,085 shares during the period. Rhumbline Advisers bought a new stake in Simulations Plus during the 2nd quarter worth approximately $126,000. OxFORD Asset Management LLP bought a new stake in Simulations Plus during the 2nd quarter worth approximately $126,000. New York State Common Retirement Fund bought a new stake in Simulations Plus during the 2nd quarter worth approximately $143,000. Finally, KCG Holdings Inc. bought a new stake in Simulations Plus during the 1st quarter worth approximately $152,000. 32.01% of the stock is currently owned by institutional investors and hedge funds.

Simulations Plus Company Profile

Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.

Receive News & Stock Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related stocks with our FREE daily email newsletter.